Geoffrey M. Parker Chemo Centryx, Inc. (CCXI) insider trading activity

Geoffrey M. Parker is Director of ChemoCentryx, Inc.. Currently has a direct ownership of 0 shares of CCXI, which is worth approximately $0. The most recent transaction as insider was on Oct 20, 2022, when has been sold 107,997 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Geoffrey M. Parker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 20 2022	SELL Sale (or disposition) back to the issuer	-	107,997 Reduced 100.0%	0 Common Stock
May 02 2022	BUY Exercise of conversion of derivative security	$180,250 $14.42 p/Share	12,500 Added 9.13%	124,413 Common Stock

Also insider at

TCDA

Tricida, Inc. Healthcare

COO, CFO and EVP

PRGO

PERRIGO Co plc Healthcare

Director

BTTX

Better Therapeutics, Inc. Healthcare

ALLO

Allogene Therapeutics, Inc. Healthcare

CHIEF FINANCIAL OFFICER

GMP